Clinical Study
Efficacy and Safety of Immunotherapy with Interferon-Gamma in the Management of Chronic Sulfur Mustard-Induced Cutaneous Complications: Comparison with Topical Betamethasone 1%
Table 2
Bivariate analyses in the IFN-γ group.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DLQI: dermatology life quality index; SCORAD: scoring atopic dermatitis. SCORAD-A, -B, and -C denote extent, intensity, and subjective symptoms of the disorder, respectively. |